IDP-121 Concentrate for solution for infusion 3 mg/mL
IDP-121-2 MYCrocytic
Phase 2 small_molecule active
Quick answer
IDP-121 Concentrate for solution for infusion 3 mg/mL for Unresectable/metastatic Small cell Lung Cancer (SCLC) is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Unresectable/metastatic Small cell Lung Cancer (SCLC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active